FDA
-
-
-
-
-
-
-
Senseonics Announces Preliminary Unaudited Revenue for Fourth Quarter 2025 and Provides Business Update
-
-
-
-
-
-
-
Mercy Places First Commercial Eversense 365: The World's First and Only 365-Day Continuous Glucose Monitor
-
-
-
-
-
-
-
Senseonics Holdings, Inc. Reports Second Quarter 2024 Financial Results
-
-
-
-
-
-
-
Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
-
-
-
-
-
-
-
Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2022 Financial Results
-
-
-
-
-
-
-
ASCENSIA DIABETES CARE ANNOUNCES FDA APPROVAL OF THE EVERSENSE E3 CONTINUOUS GLUCOSE MONITORING SYSTEM FOR USE FOR UP TO 6 MONTHS
-
-
-
-
-
-
-
Senseonics Holdings, Inc. Reports Second Quarter 2021 Financial Results
-
322,880 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

